WHO urges action on drug resistant tuberculosis

Neglected zoonotic diseases: It's now time for action urges WHO.

In addition, the WHO, Food and Agriculture Organization, and World Organization for Animal Health have joined their hands and pledged to reduce the magnitude of NZDs.[1] Subsequently, more emphasis was given to overcome the global impact of NZDs (viz. rabies, cysticercosis, echinococcosis, and leishmaniasis) at the World Health Assembly meet in 2013.[2,3] In fact, a comprehensive policy framewo...

Linking surveillance with action against drug-resistant tuberculosis.

The speed at which most countries with high burdens of multidrug-resistant tuberculosis (MDRTB) have scaled up their capacity to diagnose and treat individuals with these forms of TB has failed to keep pace with the problem. Limited availability of drug susceptibility testing, high costs and inefficiencies in the supply of second-line drugs, and inadequate capacity for the management of patient...

Gore Urges Action

Extensively drug-resistant tuberculosis.

Extensively drug-resistant (XDR) tuberculosis is defined as disease caused by Mycobacterium tuberculosis with resistance to at least isoniazid and rifampicin, any fluoroquinolone, and at least one of three injectable second-line drugs (amikacin, capreomycin, or kanamycin). The definition has applicable clinical value and has allowed for more uniform surveillance in varied international settings...

Drug Resistant Tuberculosis

Drug resistant tuberculosis (DRTB) has hit the tuberculosis control programs like a thunderbolt. It has challenged all the aspects of tuberculosis management, from diagnosis till prognosis. India has had a major contribution in DR TB worldwide, with Mumbai city being the niche for DRTB strains. DRTB has emerged distinctly as a “Creation of mankind” than solely as a “Weapon of God” to curtail th...